NeuroAct Communication offers independent consulting in neuropharmacology and preclinical drug discovery to
bioscience companies, agencies and the investment community.
offers professional and independent advice
at each stage of early CNS drug discovery.
Find out about Consulting Services
For more information, Contact
Newsletters informing of advances in NeuroAct Communication's
activities are sent to subscribers on an occasional basis.
Read the latest newsletters:
was founded by Adrian Newman-Tancredi PhD DSc
an experienced industrial neuropharmacologist.
Find out about Adrian in his Executive Profile
Read his colleagues' Endorsements
Expertise in CNS Drug Discovery
NeuroAct Communication offers expertise in preclinical
CNS pharmacology of antipsychotics, antidepressants, analgesics.
Watch WEBCASTS OF Adrian's lectureS
Adrian Newman-Tancredi PhD DSc gives lectures to a
variety of academic and industrial audiences.
Watch Webcasts of his lectures on YouTube:
Pharmacology of antipsychotics (Amsterdam, 2010)
Serotonin "biased agonists" (Vienna, 2012)